Camber Pharma Launches Generic Banzel®

Piscataway, NJ, June 1, 2021– Camber Pharmaceuticals is pleased to announce that it has launched Rufinamide Tablets, which is the generic version of Banzel®

Rufinamide Tablets are used with other medication(s) to control seizures in people who have Lennox-Gastaut syndrome.

Rufinamide Tablets are available from Camber in 200 and 400mg- 120 count bottles.

Camber Pharmaceuticals is a fully integrated international pharmaceutical company that maintains quality and integrity in all its products. Its parent company, Hetero Drugs of Hyderabad India, is one of the world’s leading API and finished dosage manufacturers. Camber’s commitment to the consumer is to bring the highest quality generic pharmaceuticals to the market to improve quality of life through cost-effective medications.

# # #

If you would like more information about this topic, please contact Megan Little at [email protected].